4Boden G. Fatty acid-induced inflammation and insulin resistancein skeletal muscle and liver[J]. Curr Diab Rep, 2006,6: 177- 181.
5Williams R. Global challenges in liver diseas[J]. Hepatology, 2006,44:521-526.
6Orlik B, Handzlik G, Olszanecka-Glinianowicz M. The role of adipokines and insulin resistance in the pathogenesis of nonal- coholic fatty liver disease[J]. Postepy Hig Med Dosw, 2010, 64:212-219.
7Chitturi S,Wong V W,Farrell G. Nonalcoholic fatty liver in A- sia.. firmly entrenched and rapidly gaining ground[J]. J Gastro- enterol Hepatol, 2011,26(Suppl 1) : 163- 172.
8Zhou Y J,Li Y Y,Nie Y Q,Ma J X, Lu L G,Shi S L, et al. Prevalence of fatty liver disease and its risk factors in the popu lation of South China[J]. World J Gastroenterol, 2007, 13 6419-6424.
9Fraser A,Longnecker M P,Lawlor D A. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors : NHANES 1999-2004[J]. Gastroenterology, 2007,133 : 1814-1820.
10Milia S, Stimac D. Nonalcoholic Fatty liver disease/steatohepa- titis., epidemiology, pathogenesis, clinical presentation and treatment[J]. Dig Dis, 2012,30 : 158-162.
